secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001193125-22-143689
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Cogent Biosciences terminates $75M ATM equity offering agreement with SVB Securities
--------------------------------------------------------------------------------

- Terminated Sales Agreement with SVB Securities LLC (f/k/a SVB Leerink) for an at-the-market offering program.
- The ATM allowed the company to sell up to $75 million of common stock at its sole discretion.
- Termination effective May 5, 2022; the facility is no longer available for use.
- Original agreement was entered into on February 8, 2021 and filed as Exhibit 1.2 to the S-3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312522143689/0001193125-22-143689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312522143689/d341370d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-143689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer